APP and Alzheimer disease: Accordingly, recent studies have shown that a treatment with fructooligosaccharides could ameliorate the cognitive impairment and neuropathology change, as well as alleviate Aβ accumulation in the brain of the APP/PS1 double transgenic mice model of AD (118, 119).